Technetium-99m-pyrophosphate imaging-based computed tomography-guided core-needle biopsy of internal oblique muscle in wild-type transthyretin cardiac amyloidosis

References

• Dorbala S, Ando Y, Bokhari S, et al. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2-evidence base and standardized methods of imaging. Circ Cardiovasc Imaging. 2021;14(7):e000029.
   PubMed Web of Science ®Google Scholar
• Singh V, Falk R, Di Carli MF, et al. State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis. J Nucl Cardiol. 2019;26(1):158–173. doi:10.1007/s12350-018-01552-4.
   PubMed Web of Science ®Google Scholar
• Gillmore JD, Maurer MS, Falk RH, et al. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation. 2016;133(24):2404–2412. doi:10.1161/CIRCULATIONAHA.116.021612.
   PubMed Web of Science ®Google Scholar
• Phull P, Sanchorawala V, Connors LH, et al. Monoclonal gammopathy of undetermined significance in systemic transthyretin amyloidosis (ATTR). Amyloid. 2018;25(1):62–67. doi:10.1080/13506129.2018.1436048.
   PubMed Web of Science ®Google Scholar
• Rubinstein SM, Stockerl-Goldstein K. How to screen for monoclonal gammopathy in patients with a suspected amyloidosis. JACC CardioOncol. 2021;3(4):590–593. doi:10.1016/j.jaccao.2021.07.001.
   PubMedGoogle Scholar
• Takahashi K, Sasaki D, Sakaue T, et al. Extracardiac accumulation of technetium-99m-pyrophosphate in transthyretin cardiac amyloidosis. JACC Case Rep. 2021;3(7):1069–1074. doi:10.1016/j.jaccas.2021.02.015.
   PubMedGoogle Scholar
• Takahashi K, Sasaki D, Yamashita M, et al. Amyloid deposit corresponds to technetium-99m-pyrophosphate accumulation in abdominal fat of patients with transthyretin cardiac amyloidosis. J Nucl Cardiol. 2022;29(6):3126–3136. doi:10.1007/s12350-021-02890-6.
   PubMed Web of Science ®Google Scholar
• Takahashi K, Hiratsuka Y, Sasaki D, et al. Technetium-99m-pyrophosphate scintigraphy can image tracer uptake in skeletal trunk muscles of transthyretin cardiac amyloidosis. Clin Nucl Med. 2023;48(1):18–24. doi:10.1097/RLU.0000000000004397.
   PubMed Web of Science ®Google Scholar
• Quarta CC, Gonzalez-Lopez E, Gilbertson JA, et al. Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis. Eur Heart J. 2017;38(24):1905–1908. doi:10.1093/eurheartj/ehx047.
   PubMed Web of Science ®Google Scholar
• Maurer MS, Bokhari S, Damy T, et al. Expert consensus recommendations for the suspicion and diagnosis of transthyretin cardiac amyloidosis. Circ Heart Fail. 2019;12(9):e006075.
   PubMed Web of Science ®Google Scholar
• Kitaoka H, Izumi C, Izumiya Y, et al. JCS 2020 guideline on diagnosis and treatment of cardiac amyloidosis. Circ J. 2020;84(9):1610–1671. doi:10.1253/circj.CJ-20-0110.
   PubMed Web of Science ®Google Scholar
• Ikeda S, Sekijima Y, Tojo K, et al. Diagnostic value of abdominal wall fat pad biopsy in senile systemic amyloidosis. Amyloid. 2011;18(4):211–215. doi:10.3109/13506129.2011.623199.
   PubMed Web of Science ®Google Scholar
• Chojniak R, Isberner RK, Viana LM, et al. Computed tomography guided needle biopsy: experience from 1,300 procedures. Sao Paulo Med J. 2006;124(1):10–14. doi:10.1590/s1516-31802006000100003.
   PubMedGoogle Scholar
• Takahashi K, Morioka H, Sasaki D, et al. Two autopsy cases of wild-type transthyretin cardiac amyloidosis who died 10 days after technetium-99m-pyrophosphate scintigraphy. J Nucl Cardiol. 2022; Online ahead of print doi:10.1007/s12350-022-03128-9.
   Google Scholar
• Hutt DF, Fontana M, Burniston M, et al. Prognostic utility of the perugini grading of 99mTc-DPD scintigraphy in transthyretin (ATTR) amyloidosis and its relationship with skeletal muscle and soft tissue amyloid. Eur Heart J Cardiovasc Imaging. 2017;18(12):1344–1350. doi:10.1093/ehjci/jew325.
   PubMed Web of Science ®Google Scholar
• Leone O, Veinot JP, Angelini A, et al. 2011 Consensus statement on endomyocardial biopsy from the association for European cardiovascular pathology and the society for cardiovascular pathology. Cardiovasc Pathol. 2012;21(4):245–274. doi:10.1016/j.carpath.2011.10.001.
   PubMed Web of Science ®Google Scholar
• Shrimpton PC, Jansen JT, Harrison JD. Updated estimates of typical effective doses for common CT examinations in the UK following the 2011 national review. Br J Radiol. 2016;89(1057):20150346. doi:10.1259/bjr.20150346.
   PubMed Web of Science ®Google Scholar
• Afşin E, Cosgun Z. A rare cough complication: internal oblique muscle hematoma. Radiol Case Rep. 2021;16(5):1015–1018. doi:10.1016/j.radcr.2021.01.059.
   PubMedGoogle Scholar
• Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48(3):452–458. doi:10.1038/bmt.2012.244.
   PubMed Web of Science ®Google Scholar
• Benson MD, Buxbaum JN, Eisenberg DS, et al. Amyloid nomenclature 2020: update and recommendations by the international society of amyloidosis (ISA) nomenclature committee. Amyloid. 2020;27(4):217–222. doi:10.1080/13506129.2020.1835263.
   PubMed Web of Science ®Google Scholar
• Pitkänen P, Westermark P, Cornwell GG. 3rd. Senile systemic amyloidosis. Am J Pathol. 1984;117(3):391–399.
   PubMed Web of Science ®Google Scholar
• Gupta S, Wallace MJ, Cardella JF, et al. Quality improvement guidelines for percutaneous needle biopsy. J Vasc Interv Radiol. 2010;21(7):969–975. doi:10.1016/j.jvir.2010.01.011.
   PubMed Web of Science ®Google Scholar
• Kennedy SA, Milovanovic L, Midia M. Major bleeding after percutaneous image-guided biopsies: frequency, predictors, and periprocedural management. Semin Intervent Radiol. 2015;32(1):26–33. doi:10.1055/s-0034-1396961.
   PubMed Web of Science ®Google Scholar
• Chung C, Kim Y, Park D. Transthoracic needle biopsy: how to maximize diagnostic accuracy and minimize complications. Tuberc Respir Dis. 2020;83(Supple 1):S17–S24. doi:10.4046/trd.2020.0156.
   PubMedGoogle Scholar
• Kim SY, Chung HW, Oh TS, et al. Practical guidelines for ultrasound-guided core needle biopsy of soft-tissue lesions: transformation from beginner to specialist. Korean J Radiol. 2017;18(2):361–369. doi:10.3348/kjr.2017.18.2.361.
   PubMed Web of Science ®Google Scholar
• Huang YY, Cheng H, Li GC. Computed tomography-guided core needle biopsy for lung nodules: low-dose versus standard-dose protocols. Wideochir Inne Tech Maloinwazyjne. 2021;16(2):355–361. doi:10.5114/wiitm.2021.103303.
   PubMedGoogle Scholar
• Kim MH. CT-guided biopsy of entirely endophytic small renal masses: diagnostic rates and complications using standard-dose and reduced-dose CT protocols. AJR Am J Roentgenol. 2017;208(5):1030–1036. doi:10.2214/AJR.16.16944.
   PubMed Web of Science ®Google Scholar
• Zensen S, Opitz MK, Grueneisen JS, et al. Radiation exposure, organ and effective dose of CT-guided liver biopsy as a function of lesion depth and size. J Radiol Prot. 2022;42(3) doi:10.1088/1361-6498/ac7e80.
   Web of Science ®Google Scholar
• Miller EJ, Campisi R, Shah NR, et al. Radiopharmaceutical supply disruptions and the use of 99mTc-hydroxymethylene diphosphonate as an alternative to 99mTc-pyrophosphate for the diagnosis of transthyretin cardiac amyloidosis: an ASNC information statement. J Nucl Cardiol. 2022;29(5):2748–2760. doi:10.1007/s12350-022-03059-5.
   PubMed Web of Science ®Google Scholar
• Hutt DF, Quigley AM, Page J, et al. Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis. Eur Heart J Cardiovasc Imaging. 2014;15(11):1289–1298. doi:10.1093/ehjci/jeu107.
   PubMed Web of Science ®Google Scholar
• Malka N, Abulizi M, Kharoubi M, et al. Extracardiac soft tissue uptake, evidenced on early 99mTc-HMDP SPECT/CT, helps typing cardiac amyloidosis and demonstrates high prognostic value. Eur J Nucl Med Mol Imaging. 2020;47(10):2396–2406. doi:10.1007/s00259-020-04753-7.
   PubMed Web of Science ®Google Scholar
• Abulizi M, Cottereau AS, Guellich A, et al. Early-phase myocardial uptake intensity of 99mTc-HMDP vs 99mTc-DPD in patients with hereditary transthyretin-related cardiac amyloidosis. J Nucl Cardiol. 2018;25(1):217–222. doi:10.1007/s12350-016-0707-9.
   PubMed Web of Science ®Google Scholar
• Ouchi Y, Rakugi H, Arai H, , et al. Redefining the elderly as aged 75 years and older: proposal from the joint committee of Japan gerontological society and the Japan geriatrics society. Geriatr Gerontol Int. 2017;17(7):1045–1047. doi:10.1111/ggi.13118.
   PubMed Web of Science ®Google Scholar
• https://www.prb.org/wp-content/uploads/2022/09/2022-World-Population-Data-Sheet-Booklet.pdf.
   Google Scholar
• Rockwood K, Song X, MacKnight C, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005;173(5):489–495. doi:10.1503/cmaj.050051.
   PubMed Web of Science ®Google Scholar
• Maurer MS, Schwartz JH, Gundapaneni B, et al. Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med. 2018;379(11):1007–1016. doi:10.1056/NEJMoa1805689.
   PubMed Web of Science ®Google Scholar
• Kazi DS, Bellows BK, Baron SJ, et al. Cost-effectiveness of tafamidis therapy for transthyretin amyloid cardiomyopathy. Circulation. 2020;141(15):1214–1224. doi:10.1161/CIRCULATIONAHA.119.045093.
   PubMed Web of Science ®Google Scholar
• Garcia-Pavia P, Rapezzi C, Adler Y, et al. Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC working group on myocardial and pericardial diseases. Eur Heart J. 2021;42(16):1554–1568. doi:10.1093/eurheartj/ehab072.
   PubMed Web of Science ®Google Scholar